 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1993 |
| Founder | Dr BPS Reddy |
| Headquarters | Hyderabad, India |
Key people | Dr Vamsi Krishna Reddy Bandi |
Number of employees | Over 22,000 |
| Website | www.hetero.com |
Hetero Drugs is an Indian pharmaceutical company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.
Hetero group employs over 21,000 people. Hetero is a player in the active pharmaceutical ingredients market and finished dosages. [1] It has marketing presence in over 127 countries.
Hetero has supplied antiretroviral drugs to patients across more than 100 countries globally. [2]
Today, Oseltamivir, sold under its brand name Fluvir, is also indicated for A[H1N1] virus, also known as swine flu.[ citation needed ]
Hetero also produces hepatitis C antivirals such as Sofovir (sofosbuvir) and Ledifos (a fixed-dose combination of sofosbuvir and ledipasvir).[ citation needed ]
Hetero Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharmaceuticals in the United States, [3] Hetero Europe in Europe, Amarox Pharma Global in Indonesia, and Richmond Labs in Argentina. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017. [4]
In 2009, as the swine flu outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name Fluvir. [5]
Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009, [6] and shipped about 80 million doses to over 60 countries. [7] Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009. [8]
The company has launched the generic version of experimental COVID-19 drug Remdesivir under brand name Covifor after acquiring license from Gilead Sciences and obtaining approval from CDSCO, the Indian drug control authority. [9] On July 29, 2020, the company launched its version of the anti viral drug Favipiravir under the brand name Favivir, after getting approval from Drugs Controller General of India (DCGI), used in the treatment of mild to moderate COVID-19 patients. [10] On November 27, 2020, Hetero Labs signed an agreement with the Russian Direct Investment Fund (RDIF) to manufacture 100 million doses of the Sputnik V vaccine. [11]
Illicium verum is a medium-sized evergreen tree native to northeast Vietnam and South China. It is a spice that closely resembles anise in flavor and is obtained from the star-shaped pericarps of the fruit of I. verum which are harvested just before ripening. Star anise oil is a highly fragrant oil used in cooking, perfumery, soaps, toothpastes, mouthwashes, and skin creams. Until 2012, when they switched to using a bacterial source, Roche Pharmaceuticals used up to 90% of the world's annual star anise crop to produce shikimic acid, a chemical intermediate used in the synthesis of oseltamivir (Tamiflu).
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai. Cipla primarily develops medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and other medical conditions.
Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Peramivir is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. It is approved for intravenous administration.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacture of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.
Beximco Pharmaceuticals Ltd, also known as Beximco Pharma, is a pharmaceutical company in Bangladesh. It is a part of Bangladesh Export Import Company Limited (BEXIMCO).
Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.
Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.
Panacea Biotec is an Indian multinational global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products.
The 2009 swine flu pandemic in New Zealand was caused by a novel strain of the A/H1N1 influenza virus. A total of 3,175 cases and 69 deaths were recorded, although a seroprevalence study estimated that around 800,000 individuals may have been infected during the initial wave of the pandemic.
Dr. Norbert Bischofberger is an Austrian scientist and one of the inventors of the antiviral drug Tamiflu generically known as oseltamivir, which is, as of 2009, the only oral medication on the market to treat influenza A and B as well as the 2009 Pandemic H1N1, the spread of which caused an ongoing pandemic in 2009. Bischofberger is currently the President & Chief Executive Officer of Kronos Bio, and previously was the Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a biopharmaceutical company specializing in antivirals.
The 2009 swine flu pandemic in India was the outbreak of swine flu in various parts of India. Soon after the outbreak of H1N1 virus in the United States and Mexico in March, the Government of India started screening people coming from the affected countries at airports for swine flu symptoms. The first case of the flu in India was found on the Hyderabad airport on 13 May, when a man traveling from US to India was found H1N1 positive. Subsequently, more confirmed cases were reported and as the rate of transmission of the flu increased in the beginning of August, with the first death due to swine flu in India in Pune, panic began to spread. As of 24 May 2010, 10193 cases of swine flu have been confirmed with 1035 deaths.
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India.
Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.
The 2015 Indian swine flu outbreak refers to an outbreak of the H1N1 virus in India, during early 2015. The states of Gujarat and Rajasthan were the worst affected.
Alvogen is an Icelandic pharmaceutical company founded in 2009. In 2014, a controlling stake in the company was acquired by CVC Capital Partners and Temasek Holdings. Alvogen has about 350 different medical and non-medical products, and both produces its own products and markets the products of brand name pharmaceutical companies.
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and crop health science products, and also provides contract manufacturing services. It is a major producer of branded oncology medicines and hepatitis C drugs. The company specialises in producing complex medicines at affordable prices. In 2019, Natco launched its crop health sciences division.
{{cite web}}: CS1 maint: archived copy as title (link){{cite web}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link){{cite web}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)